Checklists for the use of novel oral anticoagulants by the front-line clinician

Abstract

Get full access to this article

View all access options for this article.

References

Holbrook

Pereira

Labiris

. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165:1095-106.

Pirmohamed

Warfarin: almost 60 years and still causing problems. Br J Clin Pharmacol 2006;62:209-511.

Eliquis Production Monograph, Pfizer Canada Inc, Kirkland, Quebec, and Bristol-Myers Squibb Canada, Montreal Quebec. Revised February 20, 2015.

Pradaxa Production Monograph, Boehringer Ingelheim Canada Ltd, Burlington, Toronto. Revised January 7, 2015.

Xarelto Product Monograph, Bayer Inc, Toronto, Ontario. Revised February 20, 2015.

Douketis

Bell

Eikelboom

Liew

Approach to the new oral anticoagulants in family practice, part 1: comparing the options (clinical review). Can Fam Physician 2014;60:989-95.

Douketis

Bell

Eikelboom

Liew

Approach to the new oral anticoagulants in family practice, part 2: addressing frequently asked questions (clinical review). Can Fam Physician 2014;60:997-1001.

Massicotte

A practice tool for the new oral anticoagulants. Can Pharm J (Ott) 2014;147:25-32.

Cooke

Doust

Sanders

Is pulse palpation helpful in detecting atrial fibrillation? A systematic review. J Fam Practice 2006;55:130-4.

10.

Hellwig

Gulseth

Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?

Ann Pharmacother 2013;47:1478-87.

11.

Yamashita

Watanabe

Ikeda

. Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation. J Arrhythmia 2014;30:478-84.

12.

Wang

EHZ

Bolt

Decarie

. Stability of dabigatran etexilate in manufacturer’s blister pack, unit dose packaging, and community pharmacy blister pack. Can J Hosp Pharm 2015;68:16-21.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.52 MB

0.43 MB

0.52 MB